Rina Nijhawan

Rina Nijhawan is an experienced professional in pharmacovigilance and risk management, with a robust background in safety evaluation. Rina held the position of Director at GlaxoSmithKline Pharma GmbH from May 2011 to April 2019, leading pharmacovigilance activities and managing cross-functional communication regarding safety results and risk management. Prior roles include Manager of the Safety Case Management Group, where Rina oversaw training and risk management, and Principal Clinical Safety Scientist, responsible for regulatory reporting and compliance. Rina's earlier experience includes consulting at Pfizer and serving as a pharmacist and project manager at Pharmcare USA and i3 Research, respectively. Rina holds a degree in Pharmacy from The Ohio State University.